- Home
- HES vs HLN Comparison
HES vs HLN Comparison
Compare HES & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HES
- HLN
- Stock Information
- Founded
- HES 1920
- HLN 2022
- Country
- HES United States
- HLN United Kingdom
- Employees
- HES N/A
- HLN N/A
- Industry
- HES Integrated oil Companies
- HLN Package Goods/Cosmetics
- Sector
- HES Energy
- HLN Consumer Discretionary
- Exchange
- HES Nasdaq
- HLN Nasdaq
- Market Cap
- HES 43.8B
- HLN 48.2B
- IPO Year
- HES N/A
- HLN N/A
- Fundamental
- Price
- HES $138.54
- HLN $10.35
- Analyst Decision
- HES Buy
- HLN Buy
- Analyst Count
- HES 9
- HLN 1
- Target Price
- HES $159.06
- HLN $10.95
- AVG Volume (30 Days)
- HES 2.1M
- HLN 14.3M
- Earning Date
- HES 07-30-2025
- HLN 07-31-2025
- Dividend Yield
- HES 1.44%
- HLN 1.71%
- EPS Growth
- HES 10.59
- HLN 38.94
- EPS
- HES 7.21
- HLN 0.20
- Revenue
- HES $12,270,000,000.00
- HLN $14,062,871,660.00
- Revenue This Year
- HES N/A
- HLN $3.63
- Revenue Next Year
- HES $15.79
- HLN $4.37
- P/E Ratio
- HES $19.27
- HLN $25.82
- Revenue Growth
- HES 9.70
- HLN N/A
- 52 Week Low
- HES $123.79
- HLN $8.25
- 52 Week High
- HES $161.69
- HLN $11.42
- Technical
- Relative Strength Index (RSI)
- HES 54.83
- HLN 38.09
- Support Level
- HES $137.42
- HLN $10.39
- Resistance Level
- HES $147.06
- HLN $10.61
- Average True Range (ATR)
- HES 2.88
- HLN 0.12
- MACD
- HES -0.14
- HLN -0.07
- Stochastic Oscillator
- HES 47.77
- HLN 7.22
About HES Hess Corporation
Hess is an independent oil and gas producer with key assets in the Bakken Shale, Guyana, the Gulf of Mexico, and Southeast Asia. At the end of 2024, the company reported net proved reserves of 1.44 billion barrels of oil equivalent. Net production averaged 481 thousand barrels of oil equivalent per day in 2024, at a ratio of 79% oil and natural gas liquids and 21% natural gas.
About HLN Haleon plc (Each representing two)
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.